GSTO1 and Alzheimer disease: In contrast, when a more precise neuropsychological test battery, such as a CERAD‐Plus, was used, ≈40% of these age‐ and gender‐matched controls were diagnosed as MCI, and a significant enrichment of the GSTO1*C allele was detected in both the AD and MCI patients compared to the cognitively healthy control group.